Home > News > featured news > Apollo Medical Holdings, Inc. Announces Acquisition of Value-Based Care Technology Platform Orma Health

HEALTH TECHNOLOGY

Apollo Medical Holdings, Inc. Announces Acquisition of Value-Based Care Technology Platform Orma Health

Apollo Medical Holdings, Inc. | January 28, 2022

Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company"), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it has acquired 100% of the fully diluted capitalization of Orma Health, Inc., and Provider Growth Solutions LLC (together, "Orma Health") in accordance with an agreement between ApolloMed, Orma Health and certain equity holders of Orma Health.

Founded in 2020, Orma Health has helped many physician groups transition to and succeed in the delivery of value-based care, enabling them to focus on their passion—caring for patients. Orma Health's real-time Clinical AI platform ingests data from multiple sources and utilizes advanced risk-stratification models to identify patients for various clinical programs, including remote patient monitoring ("RPM"), mental health support, chronic disease management, and more. Its clinical platform is also deeply integrated with Orma Health's proprietary RPM ecosystem, which consists of smart health devices and a suite of technology tools to help manage patients' health. Through its suite of AI-driven solutions, Orma Health currently serves over 4,000 aligned Medicare beneficiaries in a Direct Contracting Entity ("DCE") and over 2,500 patients in California, Nevada, Arizona and Texas through its RPM platform.

"We are excited about integrating Orma Health's business and technological capabilities with those of ApolloMed, tapping their leadership team's experience in working with DCEs and helping risk-bearing provider groups in the delivery of value-based care as we augment our capabilities to support providers in various Centers for Medicare & Medicaid Services Innovation Models. We believe this acquisition will further differentiate ApolloMed's technology platform and analytic capabilities while adding complementary lines of business to our operations that serve as business development opportunities."

Brandon Sim, Co-Chief Executive Officer of ApolloMed

Through leveraging its proprietary technology platform and extensive value-based care experience, ApolloMed has historically demonstrated tremendous success participating in Centers for Medicare & Medicaid Services ("CMS") Innovation Models. The acquisition of Orma Health serves to accelerate ApolloMed's product roadmap in developing an end-to-end technology platform that enables providers to succeed in all CMS Innovation Models, including DCE. Orma Health's real-time Clinical AI and RPM technologies will also be integrated into ApolloMed's existing solutions for its managed care populations and will further enhance ApolloMed's technology and analytics offering to its 1.2 million Medicare Advantage, Managed Medicaid, Commercial, and ACA members nationwide. This will allow ApolloMed providers to receive an additional layer of real-time, actionable insights and continue delivering high-quality care to their patients, tailored to their membership populations. As ApolloMed looks to expand its membership and enter new geographies, there are significant business development opportunities in deepening Orma Health's relationships with existing RPM providers and patients and extending that to ApolloMed's managed care and CMS Innovation Model solutions and offerings.

As part of the acquisition, Neil Ahuja, co-founder and Chief Executive Officer of Orma Health, will join ApolloMed as President, Provider Solutions and spearhead continued efforts to enable physicians to transition to value-based care models successfully. Yubin Park, co-founder and Chief Technology Officer of Orma Health, will join ApolloMed as Chief Analytics Officer and lead the continued development and integration of Orma Health's AI-driven provider enablement technology into ApolloMed's technology platform.

Mr. Ahuja commented, "We are pleased to be joining ApolloMed, bringing Orma Health's core competencies in developing innovative healthcare technologies that drive tangible outcomes for providers and their patients. ApolloMed has been a leading healthcare management company with a long history of successfully and profitably empowering physicians in the delivery of value-based care, making it the perfect partner for us. We look forward to contributing our expertise to expanding ApolloMed's MSO capabilities and the potential future opportunities that lie ahead."

Mr. Park added, "I am excited to begin working closely with the ApolloMed team on integrating Orma Health's technologies with that of ApolloMed. At Orma Health, we, like ApolloMed, believe that data is king. The information we gather and analyze about our members over the years is critical to our ability to deliver the best healthcare experience and outcomes for patients. We are thrilled that Orma Health is now a part of ApolloMed's worthy mission of empowering providers in delivering high-quality care and improved outcomes for its members."

According to the terms of the agreement, a portion of the purchase price was paid in cash to the equity holders of Orma Health upon the closing of the transaction, another portion was paid in ApolloMed stock to the equity holders of Orma Health upon the closing of the transaction, and the remainder of the purchase price is to be paid in a combination of cash and stock to the equity holders contingent upon Orma Health achieving certain operational milestones over the 18 months after the closing. The Company will fund the transaction from cash on hand and shares of ApolloMed stock.

About Apollo Medical Holdings, Inc.
ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and a Next Generation Accountable Care Organization (NGACO).

Spotlight

Philips Ultrasound Service and Technology Maximizer Value Proposition

Philips Ulrasound offers services designed around your needs and solutions that enable you to streamline and enhance the care you provide.

More featured news

Spotlight

Philips Ultrasound Service and Technology Maximizer Value Proposition

Philips Ulrasound offers services designed around your needs and solutions that enable you to streamline and enhance the care you provide.

Related News

HEALTHCARE ANALYTICS

Personalized care company Validic acquires Trapollo

PRNewswire | May 16, 2023

Validic Inc., a market-leading digital health and personalized care company, has acquired the assets of Trapollo LLC, a connected health, technical support, and device logistics provider that helps healthcare organizations care for patients at home. Trapollo is a wholly-owned subsidiary of Cox Communications, Inc. With the acquisition of these Trapollo assets, Validic rounds out its core capabilities and becomes the company best positioned to make personalized healthcare a practical reality for patients and clinicians. Validic's EHR-integrated healthcare application ingests remotely collected health data from the world's largest health IoT platform to help healthcare organizations personalize chronic condition management, remote care, and support for healthy living. Adding in-house device logistics and technical support to a platform built for scale means that Validic offers the most proven way for healthcare providers to personalize care for their entire patient population. Even prior to the acquisition, Validic and Trapollo were jointly supporting the largest personalized care program in the country at a leading healthcare integrated delivery network on the West Coast, with more than 300,000 patients enrolled and thousands of devices shipped since inception. Now, for the first time, this winning solution is available for healthcare organizations nationwide. "We live in a time where consumers expect personalized experiences, and they aren't receiving them from their healthcare providers — 76% of patients are frustrated leaving their medical appointments and 69% would switch providers for better service. Imagine a system that helps clinicians efficiently deliver personalized care for every patient at scale," said Validic CEO Drew Schiller. "With the Trapollo assets, Validic, which has long been the leader in scaling remote and personalized healthcare programs, is now also a leading connected health and device logistics company, supporting the full range of personalized care programs - from BYO-tech, low-touch programs to high-risk, high-touch, fully kit-based remote monitoring and everything in between," said Schiller. Healthcare is not one size fits all. Patients have different goals and need different levels of care at different times. Validic offers healthcare organizations a single, cost-effective, EHR-embedded solution that Enables the creation of remote programs to support multiple clinical applications and patient support needs Integrates personal health data as a first-class citizen of the EHR — with program enrollment and visualizations in the patient chart, writing data to EHR flowsheets, and surfacing clinical alerts via the in-basket and in-basket pools Helps clinical teams operate more efficiently and effectively; 88% of clinicians say Validic saves them time Meets the full scope of patient device and support needs, from BYO-everything to pre-paired kits and phone support Eliminates the need to support multiple point solutions with a comprehensive enterprise platform Former Trapollo and current Validic Senior Vice President and General Manager Steve Nester echoed Schiller's enthusiasm and optimism stating: "We are joining Validic at a pivotal time in healthcare, as patients demand personalized and more convenient healthcare experiences that meet them where they are. We will bring our experience and expertise in device logistics, compassionate technical support, supply chain, and connected health from Trapollo to further Validic's mission of improving the quality of life by making personal data actionable." Validic is headquartered in Durham, N.C. Trapollo's former distribution center, which will now be operated by Validic, will remain in Sterling, VA. With the transaction, Cox becomes an investor in Validic. About Validic Founded in 2010, Validic Inc. is a digital health and personalized care company devoted to our mission of improving the quality of human life by making personal data actionable. With the world's largest health IoT platform and EHR-embedded remote care application, we help healthcare organizations give every person tailored interventions and personalized care, improving healthcare efficiency and delivery, and empowering people to play an active role in their health and well-being.

FUTURE OF HEALTHCARE, MEDICAL DEVICES

WellSky® Introduces Enhanced Intelligence to the Discharge Process in CarePort Suite of Solutions to Facilitate Superior Care Transitions

Businesswire | April 21, 2023

WellSky, a leading health and community care technology company, today announced expanded capabilities in its CarePort suite of care transition solutions. These new enhancements equip discharge planners, care managers, and care coordinators with enhanced intelligence at the point of discharge to help them make more informed decisions and ensure patients receive the best possible care and support as they transition from the hospital to home or another care setting. WellSky and CarePort recently expanded its network with the acquisition of Curaspan. Curaspan clients using CarePort Discharge can now take advantage of an expanded solution set. “We're thrilled to offer our clients, including those in our newly expanded network available through Curaspan, capabilities to better engage patients and families and enhance their care planning and decision making throughout the discharge process,” said Dr. Lissy Hu, president of connected networks at WellSky. “Through these enhancements, WellSky is enabling care providers to deliver the right care, at the right time, in the right setting to achieve better health outcomes.” By extending CarePort Connect into the care transitions solutions, providers gain seamless access directly from their discharge planning workflows. This access delivers a deeper knowledge of past post-acute care utilization which is critical to help providers determine the appropriate level of care needed post-discharge and create a care plan tailored to the patient's specific needs. Accessing clinical data and encounter history at a patient’s most vulnerable point of transition can help reduce hospital readmissions and connect patients to the most appropriate care. CarePort Guide, available in CarePort Discharge, gives hospitals and health systems access to a more robust patient choice tool to assist patients and families in selecting high-quality post-acute care. CarePort Guide provides access to proprietary post-acute quality scores, highlights high-performing post-acute networks and collaboratives, and offers more robust agency profiles and guides, all sharable via text and email. By increasing patient satisfaction with the discharge process and reducing discharge delays, CarePort Guide brings a superior post-acute care selection tool to the market and can increase the number of patients attending in-network skilled nursing facilities by 7%. About WellSky® WellSky is one of America’s largest and most innovative healthcare technology companies leading the movement for intelligent, coordinated care. Our proven software, analytics, and services power better outcomes and lower costs for stakeholders across the health and community care continuum. In today’s value-based care environment, WellSky helps providers, payers, health systems, and community organizations scale processes, improve collaboration for growth, harness the power of data analytics, and achieve better outcomes by further connecting clinical and social care. WellSky serves more than 20,000 client sites — including the largest hospital systems, blood banks, cell therapy labs, home health and hospice franchises, post-acute providers, government agencies, and human services organizations. Informed by more than 40 years of providing software and expertise, WellSky anticipates clients’ needs and innovates relentlessly to build healthy, thriving communities.

AI, DIGITAL HEALTHCARE

Caregility Unveils Multiple AI-Enhanced Hybrid Care Solutions that Harness the Power of Caregility Cloud™ Telehealth Platform

Businesswire | April 19, 2023

Caregility, an enterprise telehealth leader dedicated to connecting care for patients and clinicians everywhere, today announced a new portfolio of AI-enhanced hybrid care solutions built on Caregility Cloud™, its Best in KLAS virtual care platform (non-EMR). The enhancements reduce technology investment risks for hospitals and health systems by offering the flexibility to choose those health AI applications that are the best fit for their environment and needs without creating more IT silos that could hamper workflow and congest networks. Interest in hybrid care models that blend in-person care with virtual encounters has increased significantly as health systems look to optimize patient care delivery amid workforce shortages. Caregility Cloud™ is a robust telehealth foundation that helps modernize care delivery with advanced video and audio streaming technologies. Transformative clinical programs built on the platform include virtual nursing, tele-ICU, continuous patient observation, and virtual visits. The AI enhancements announced today unlock even more value for overburdened caregivers and administrative teams struggling to keep up with rising costs and increased demand. A computer vision application analyzes live video streams of patients and their environment to detect movement and changes that could lead to adverse events such as falls or self-harm. A contactless monitoring system continuously captures patient vital signs, detecting variations in heart rate, breathing patterns, and movement that could be indicative of physiological events like awakening from sleep or an induced coma. An ambient clinical intelligence algorithm generates documentation from live clinician and patient conversations for the patient’s electronic health record. “Integrating artificial intelligence technologies with our leading virtual care platform advances care delivery and empowers the clinicians we serve to focus on patient care,” states Mike Brandofino, President and COO at Caregility. “AI development in healthcare is in the beginning stages. Our customers are asking us for options that they can implement now but won’t box them into an investment that might quickly become obsolete. By harnessing the power of Caregility Cloud™ as the platform of choice, we provide the resilient virtual care infrastructure and endpoints while our business partners focus on AI advancement.” “Combining virtual care solutions and AI technology yields tremendous potential to enhance and improve a variety of clinical workflows in acute care settings,” said Pete McLain, Chief Strategy Officer at Caregility. “Artificial intelligence has the potential to enhance and augment – not replace – care teams, helping them save time, capture more meaningful patient data, and support clinical decisions and interventions that lead to better care and improved patient outcomes.” The Caregility Cloud™ Ecosystem is a growing network of Caregility business partners brought together for better healthcare. The new AI innovators joining the ecosystem include Abridge, Ouva, and Xandar Kardian, who are committed to integrating their transformative AI-enhanced hybrid care solutions with the Best in KLAS virtual care platform. Abridge, a leader in the clinical adaptation of generative AI, introduces ambient clinical intelligence for Caregility Cloud™, capturing relevant medical documentation from clinical conversations with patients in near real-time. Ouva, a pioneer in the clinical application of computer vision, brings AI-powered continuous patient and patient room observation to Caregility Cloud™ adopters, tracking patient and visitor movement to alert care teams to potential patient safety concerns such as falls, elopement, or self-harm. The Ouva solution also helps optimize workforce efficiency, with bedside shift planning and bed turnover processes. Xandar Kardian, an innovator in radar-based contactless patient monitoring, adds continuous vital sign and motion capture to Caregility Cloud™, delivering real-time data on patients’ resting heart rate, respiratory rate, and motion patterns to remote clinical teams to assess trends and meaningful changes in patient conditions. The Caregility Cloud™ virtual care platform also leverages operational AI to remotely monitor telehealth endpoint systems and initiate self-healing commands if equipment is not performing properly, enabling health systems to manage large telehealth system deployments at scale and across multiple sites. About Caregility Caregility Corporation is dedicated to connecting patients and clinicians everywhere with its Caregility Cloud™ virtual care platform. Awarded the Best in KLAS Virtual Care Platform (non-EMR) in 2021, 2022, and 2023, Caregility Cloud™ powers a purpose-built ecosystem of enterprise telehealth solutions across the care continuum. Caregility provides secure, reliable, and HIPAA-compliant audio and video communication designed for any device and clinical workflow, in both acute and ambulatory settings. Today Caregility supports more than 1,000 hospitals across over 75 health systems with over six million virtual care sessions hosted annually.